Bone Biologics Corporation (BBLG)
USD 1.03
(-1.9%)
USD 1.03
(-1.9%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | - USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 11.72 Million USD | 3.56% |
| 2019 | 11.32 Million USD | 25.78% |
| 2018 | 9 Million USD | 9.36% |
| 2017 | 8.22 Million USD | 9.99% |
| 2016 | 7.48 Million USD | 33.23% |
| 2015 | 5.61 Million USD | -23.11% |
| 2014 | 7.3 Million USD | 76.93% |
| 2013 | 4.12 Million USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - USD | 0.0% |
| 2024 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 FY | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q4 | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2021 Q4 | - USD | -100.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q2 | 12.49 Million USD | 4.77% |
| 2021 Q3 | 12.76 Million USD | 2.22% |
| 2021 Q1 | 11.92 Million USD | 1.7% |
| 2020 Q1 | 11.44 Million USD | 1.13% |
| 2020 FY | 11.72 Million USD | 3.56% |
| 2020 Q2 | 11.52 Million USD | 0.67% |
| 2020 Q3 | 11.59 Million USD | 0.65% |
| 2020 Q4 | 11.72 Million USD | 1.06% |
| 2019 Q1 | 9.7 Million USD | 7.78% |
| 2019 FY | 11.32 Million USD | 25.78% |
| 2019 Q3 | 11.2 Million USD | 4.67% |
| 2019 Q4 | 11.32 Million USD | 1.07% |
| 2019 Q2 | 10.7 Million USD | 10.31% |
| 2018 Q3 | 9 Million USD | -1.78% |
| 2018 FY | 9 Million USD | 9.36% |
| 2018 Q1 | 8.39 Million USD | 2.03% |
| 2018 Q2 | 9.16 Million USD | 9.13% |
| 2018 Q4 | 9 Million USD | 0.0% |
| 2017 Q3 | 10.09 Million USD | 12.2% |
| 2017 FY | 8.22 Million USD | 9.99% |
| 2017 Q4 | 8.22 Million USD | -18.44% |
| 2017 Q2 | 8.99 Million USD | 10.15% |
| 2017 Q1 | 8.16 Million USD | 9.11% |
| 2016 FY | 7.48 Million USD | 33.23% |
| 2016 Q2 | 5.64 Million USD | 5.98% |
| 2016 Q1 | 5.32 Million USD | -5.14% |
| 2016 Q4 | 7.48 Million USD | 25.46% |
| 2016 Q3 | 5.96 Million USD | 5.64% |
| 2015 FY | 5.61 Million USD | -23.11% |
| 2015 Q1 | 7.42 Million USD | 1.64% |
| 2015 Q4 | 5.61 Million USD | 3.2% |
| 2015 Q3 | 5.44 Million USD | 3.3% |
| 2015 Q2 | 5.26 Million USD | -29.04% |
| 2014 Q3 | 3.18 Million USD | -27.32% |
| 2014 FY | 7.3 Million USD | 76.93% |
| 2014 Q4 | 7.3 Million USD | 129.26% |
| 2014 Q2 | 4.38 Million USD | 0.0% |
| 2014 Q1 | - USD | -100.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | 4.12 Million USD | 0.0% |
| 2013 FY | 4.12 Million USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 541.67 Million USD | 100.0% |
| Nemaura Medical Inc. | 20.03 Million USD | 100.0% |
| NeuroPace, Inc. | 72.39 Million USD | 100.0% |
| LENSAR, Inc. | 2.3 Million USD | 100.0% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | 100.0% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | 100.0% |
| Apyx Medical Corporation | 38.5 Million USD | 100.0% |
| Cutera, Inc. | 431.91 Million USD | 100.0% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | 100.0% |
| BioSig Technologies, Inc. | 452 Thousand USD | 100.0% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 100.0% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 100.0% |
| Axonics, Inc. | 27.61 Million USD | 100.0% |
| IRIDEX Corporation | 2.74 Million USD | 100.0% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 100.0% |
| TELA Bio, Inc. | 42.78 Million USD | 100.0% |
| Tivic Health Systems, Inc. | 369 Thousand USD | 100.0% |
| RxSight, Inc. | 3.01 Million USD | 100.0% |
| Align Technology, Inc. | 96.96 Million USD | 100.0% |
| INVO Bioscience, Inc. | 8.68 Million USD | 100.0% |
| electroCore, Inc. | 626 Thousand USD | 100.0% |
| Telesis Bio, Inc. | 34.38 Million USD | 100.0% |
| Viemed Healthcare, Inc. | 10.27 Million USD | 100.0% |
| Quipt Home Medical Corp. | 98.94 Million USD | 100.0% |
| Anika Therapeutics, Inc. | 29.03 Million USD | 100.0% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 100.0% |
| Lucid Diagnostics Inc. | 15.25 Million USD | 100.0% |
| Dynatronics Corporation | 6.68 Million USD | 100.0% |
| Modular Medical, Inc. | 1.19 Million USD | 100.0% |
| ReShape Lifesciences Inc. | 262 Thousand USD | 100.0% |
| Talis Biomedical Corporation | 19.66 Million USD | 100.0% |
| PetVivo Holdings, Inc. | 1.36 Million USD | 100.0% |
| InMode Ltd. | 9.01 Million USD | 100.0% |
| Envoy Medical, Inc. | 404 Thousand USD | 100.0% |
| Bruker Corporation | 1.37 Billion USD | 100.0% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | 100.0% |
| DexCom, Inc. | 2.59 Billion USD | 100.0% |
| Nexalin Technology, Inc. | 4463.00 USD | 100.0% |
| PAVmed Inc | 48.72 Million USD | 100.0% |
| Viveve Medical, Inc. | 5.34 Million USD | 100.0% |
| Cerus Corporation | 95.99 Million USD | 100.0% |
| Movano Inc. | 252 Thousand USD | 100.0% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 100.0% |
| Nexalin Technology, Inc. | 4463.00 USD | 100.0% |
| IceCure Medical Ltd | 599 Thousand USD | 100.0% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 100.0% |
| enVVeno Medical Corporation | 1.4 Million USD | 100.0% |
| 908 Devices Inc. | 5.94 Million USD | 100.0% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | 100.0% |
| Orthofix Medical Inc. | 134.19 Million USD | 100.0% |
| Surmodics, Inc. | 29.4 Million USD | 100.0% |
| Nuwellis, Inc. | 981 Thousand USD | 100.0% |
| Outset Medical, Inc. | 136.18 Million USD | 100.0% |
| Venus Concept Inc. | 79.69 Million USD | 100.0% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 100.0% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 100.0% |
| Nano-X Imaging Ltd. | 8.39 Million USD | 100.0% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | 100.0% |
| Inogen, Inc. | 21.92 Million USD | 100.0% |
| IRadimed Corporation | 2.04 Million USD | 100.0% |
| MaxCyte, Inc. | 18.74 Million USD | 100.0% |
| Pulmonx Corporation | 41.42 Million USD | 100.0% |
| PAVmed Inc. | 48.72 Million USD | 100.0% |
| iCAD, Inc. | 461 Thousand USD | 100.0% |
| OrthoPediatrics Corp. | 23.76 Million USD | 100.0% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | 100.0% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | 100.0% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | 100.0% |
| SI-BONE, Inc. | 38.99 Million USD | 100.0% |
| Semler Scientific, Inc. | 70 Thousand USD | 100.0% |
| Beyond Air, Inc. | 17.83 Million USD | 100.0% |
| FONAR Corporation | 41.67 Million USD | 100.0% |
| AxoGen, Inc. | 69.29 Million USD | 100.0% |
| Biotricity, Inc. | 23.87 Million USD | 100.0% |
| Cytosorbents Corporation | 18.31 Million USD | 100.0% |
| ZimVie Inc. | 521.92 Million USD | 100.0% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 100.0% |
| Inari Medical, Inc. | 32.04 Million USD | 100.0% |
| UFP Technologies, Inc. | 46.03 Million USD | 100.0% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | 100.0% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | 100.0% |
| Sight Sciences, Inc. | 35.41 Million USD | 100.0% |
| Insulet Corporation | 1.44 Billion USD | 100.0% |
| Profound Medical Corp. | 7.9 Million USD | 100.0% |
| Bioventus Inc. | 409.47 Million USD | 100.0% |
| InspireMD, Inc. | 1.59 Million USD | 100.0% |
| BrainsWay Ltd. | 471 Thousand USD | 100.0% |
| BIOLASE, Inc. | 17.91 Million USD | 100.0% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | 100.0% |
| Tenon Medical, Inc. | 1.17 Million USD | 100.0% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | 100.0% |
| CVRx, Inc. | 30.61 Million USD | 100.0% |
| AdaptHealth Corp. | 2.29 Billion USD | 100.0% |
| Sintx Technologies, Inc. | 4.24 Million USD | 100.0% |
| Acutus Medical, Inc. | 38.47 Million USD | 100.0% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | 100.0% |
| NanoVibronix, Inc. | 5000.00 USD | 100.0% |
| Quanterix Corporation | 41.46 Million USD | 100.0% |
| LivaNova PLC | 640.4 Million USD | 100.0% |
| Co-Diagnostics, Inc. | 2.99 Million USD | 100.0% |
| Varex Imaging Corporation | 469.5 Million USD | 100.0% |
| Vivani Medical, Inc. | 20.69 Million USD | 100.0% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 100.0% |
| Sensus Healthcare, Inc. | 783 Thousand USD | 100.0% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 100.0% |
| TransMedics Group, Inc. | 515.94 Million USD | 100.0% |
| ReWalk Robotics Ltd. | 1.9 Million USD | 100.0% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | 100.0% |
| Spectral AI, Inc. | 1.28 Million USD | 100.0% |
| Hyperfine, Inc. | 185 Thousand USD | 100.0% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 100.0% |
| Biomerica, Inc. | 785 Thousand USD | 100.0% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 100.0% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | 100.0% |
| Silk Road Medical, Inc | 84.63 Million USD | 100.0% |